×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

2110 Total Publications

Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients
Brendel, M., Pogarell, O., Xiong, G., Delker, A., Bartenstein, P., & Rominger, A.
PMID: 25631614 ; PMCID:5849231 ; 2015; Journal European Journal of Nuclear Medicine and Molecular Imaging; vol. 42; no. 5; pp. 716-24; doi:10.1007/s00259-014-2975-4
Alzheimer's disease biomarkers as outcome measures for clinical trials in MCI
Caroli, A., Prestia, A., Wade, S., Kewei, C., Ayutyanont, N., Landau, S., … Initiative, for the A. D. N.
PMID: 25437302 ; PMCID:4437812 ; 2015; Journal Alzheimer's Disease and Associated Disorders; vol. 29; no. 2; pp. 101-109; doi:10.1097/WAD.0000000000000071
Improved Power for Characterizing Longitudinal Amyloid-b PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region
Chen K1, Roontiva A2, Thiyyagura P2, Lee W2, Liu X2, Ayutyanont N2, Protas H2, Luo JL2, Bauer R2, Reschke C2, Bandy D2, Koeppe RA3, Fleisher AS4, Caselli RJ5, Landau S6, Jagust WJ6, Weiner MW7, Reiman EM8; Alzheimer’s Disease Neuroimaging Initiative.
PMID: 25745091 ; 2015; Journal J Nucl Med; vol. 56; no. 4; pp. 560-6; doi:10.2967/jnumed.114.149732
Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging
Chiotis, K., Carter, S. F., Farid, K., Savitcheva, I., & Nordberg, A.
PMID: 26130168 ; PMCID:4521094 ; 2015; Journal European Journal of Nuclear Medicine and Molecular Imaging; vol. 42; no. 10; pp. 1492-506; doi:10.1007/s00259-015-3115-5
Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementiafrom Mild Cognitive Impairment.
Chung JK, Plitman E, Nakajima S, et al.
PMID: 26519442 ; 2015; Journal Journal of Alzheimer's Disease; vol. 49; no. 3; pp. 743-54; doi:10.3233/JAD-150679
Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders
T. C. Durazzo, N. Mattsson, M. W. Weiner and I. Alzheimer's Disease Neuroimaging
PMID: 25847292 ; PMCID:5967295 ; 2015; Journal Nicotine Tob Res; vol. 18; no. 2; pp. 204-11; doi:10.1093/ntr/ntv075
Inherent Structure Based Multi-view Learning with Multi-template Feature Representation for Alzheimer’s Disease Diagnosis
M. Liu, D. Zhang, E. Adeli and D. Shen
2015; Journal IEEE Trans Biomed Eng; vol. 63; no. 7; pp. 1473-82; doi:10.1109/TBME.2015.2496233
Improved longitudinal [18F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction
Brendel, M., Högenauer, M., Delker, A., Sauerbeck, J., Bartenstein, P., Seibyl, J., & Rominger, A.
PMID: 25482269 ; 2015; Journal Neuroimage; vol. 108; pp. 450-459; doi:10.1016/j.neuroimage.2014.11.055
Feature Selection Based on the SVM Weight Vector for Classification of Dementia
Bron, E., Smits, M., Niessen, W., & Klein, S.
PMID: 25974958 ; 2015; Journal IEEE Journal of Biomedical and Health Informatics; vol. 19; no. 5; pp. 1617-1626; doi:10.1109/JBHI.2015.2432832